Tips and tricks from our application experts: AAV analysis with CE

Jan 24, 2025 | Biopharma, BioPhase 8800 system, Blogs, PA 800 system | 0 comments

Read time: 2 minutes

Peter Holper, Staff Applications Scientist at SCIEX, US, shares his tips and tricks on AAV analysis using CE with the BioPhase 8800 system and the PA 800 Plus system.

Tip 1: Leverage the flexibility in injection modes

When starting out with a new viral vector product, my recommendation is to compare three different modes of injection using UV detection. First, start with a standard electrokinetic injection, which allows for the highest theoretical resolution. Next, use a pressure/ hydrodynamic injection, which will inject the same plug regardless of sample ionic strength and provide a quick estimate of the titer. Finally, use a field-amplified sample stacking (FASS) injection to achieve the highest sensitivity, while understanding it is the most sensitive injection method to the ionic strength of the matrix. Comparing these three peak profiles can give significant insight into the optimal separation conditions for each molecule analyzed.

Tip 2: Deal with low sample amounts

During early-stage development of AAV vectors, oftentimes only a few micrograms of proteins or less are available for analytics. However, most analytical technology is not practical for applications with low protein concentration or small sample volumes. To improve the sensitivity of CE-SDS, my recommendation is to use laser-induced fluorescence (LIF) detection instead of UV absorbance. Comparing the results from the different injection types (tip 1) will help you determine if additional sensitivity and transition to LIF detection is needed.

Tip 3: Optimize fluorescence dye labelling

Labeling procedure can pose challenges and require optimization for each product. Currently, the most common fluorescent dye used in CE-SDS-LIF is Chromeo P503, which has a low quantum yield when not bound to a protein and thus does not require additional cleanup after conjugation. When optimizing the labeling procedure with Chromeo P503, I find the dye-to-protein ratio to be the most important factor. If this ratio is not optimal, low signal or high peak tailing is often observed. I find that estimating the protein titer by referring to the peak area achieved with pressure injection (tip 1) can be highly beneficial, since only the genome titer may be known at this point.

Pharma perspectives: The influence of LC-MS innovation on drug development outsourcing

It is no secret that (bio)pharmaceutical research and development is complex, both scientific and regulatory processes. Working for a contract research organization and more recently for SCIEX has provided an interesting perspective on trends the market experiences that affect many of us.

Overcoming uncertainty in your PFAS analysis

Just like gum on the bottom of a shoe, the existence of per- and poly-fluorinated alkyl substances (PFAS) in our environment is a sticky one. If you’re in the field of environmental testing, then you’re all too familiar with the threat these substances have on public health. While we have learned a lot about them over the years, there is still much more to understand. With the right detection methods, we can gather the information we need to empower us to make informed decisions on reducing the risks they impose.

6 Signs it’s time for a new vendor

A lab’s success depends on many factors from instrument quality to efficient operations, including being partnered with the right vendor. A vendor is more than just a supplier. They should provide you with a high-level quality of support in maximizing the lifespan and performance of your systems, reducing downtime, enhancing ROI and more. How do you know if you’re partnered with the right one? Here are six signs it might be time to find someone new.

Posted by

Peter Holper has over 15 years of experience in biopharma, including his role as an analytical chemist at Eli Lilly and Company where he was responsible for developing the analytical control strategy for bioproducts. He has extensive experience in analytical method development for biologics and held various positions with increasing responsibility. Peter currently works at SCIEX as a Staff Applications Scientist in Redwood City, California, where he is responsible for developing and optimizing CE applications and providing customer demo sample analysis support.

0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial